PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-alpha-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY


Wedemeyer H., Yurdaydin C., Ernst S., Caruntu F. A. , Curescu M. G. , Yalcin K., ...More

49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, London, Canada, 9 - 13 April 2014, vol.60 identifier